BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
67 hedge funds and large institutions have $218M invested in Biotech Acquisition Company Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-9
Holders Change %
-11.84%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
9
Increased
13
Reduced
13
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$20M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
$12.5M |
| 3 |
GCL
Glazer Capital LLC
New York
|
$6.3M |
| 4 |
RL
RPO LLC
Stamford,
Connecticut
|
$6.22M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
$3.48M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$596K | -60,522 | Closed |
|
|
NAM
77
Nexpoint Asset Management
Dallas,
Texas
| – | -$343K | -34,781 | Closed |
|
|
SCA
78
Salient Capital Advisors
Houston,
Texas
| – | -$317K | -32,175 | Closed |
|
|
BCM
79
BCK Capital Management
Stamford,
Connecticut
| – | -$268K | -27,146 | Closed |
|
|
SFM
80
Spartan Fund Management
Toronto, Ontario,
Canada
| – | -$302K | -24,530 | Closed |
|
|
OCAM
81
Owl Creek Asset Management
New York
| – | -$197K | -20,000 | Closed |
|
|
DIG
82
DeepCurrents Investment Group
New York
| – | -$175K | -17,730 | Closed |
|
83
HighTower Advisors
Chicago,
Illinois
| – | -$114K | -11,446 | Closed |
|
|
AA
84
Ancora Advisors
Cleveland,
Ohio
| – | -$109K | -11,100 | Closed |
|
|
ACM
85
Atalaya Capital Management
New York
| – | -$68K | -6,875 | Closed |
|